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From solution to in-cell study of the chemical
reactivity of acid sensitive functional groups:
a rational approach towards improved cleavable
linkers for biospeciﬁc endosomal release†
Sylvain A. Jacques,‡a Geoﬀray Leriche,‡a Michel Mosser,a Marc Nothisen,b
Christian D. Muller,c Jean-Serge Remyb and Alain Wagner*a
pH-Sensitive linkers designed to undergo selective hydrolysis at
acidic pH compared to physiological pH can be used for the selec-
tive release of therapeutics at their site of action. In this paper, the
hydrolytic cleavage of a wide variety of molecular structures that
have been reported for their use in pH-sensitive delivery systems
was examined. A wide variety of hydrolytic stability proﬁles were
found among the panel of tested chemical functionalities. Even
within a structural family, a slight modiﬁcation of the substitution
pattern has an unsuspected outcome on the hydrolysis stability.
This work led us to establish a ﬁrst classiﬁcation of these groups
based on their reactivities at pH 5.5 and their relative hydrolysis at
pH 5.5 vs. pH 7.4. From this classiﬁcation, four representative
chemical functions were selected and studied in-vitro. The results
revealed that only the most reactive functions underwent signiﬁ-
cant lysosomal cleavage, according to ﬂow cytometry measure-
ments. These last results question the acid-based mechanism of
action of known drug release systems and advocate for the impor-
tance of an in-depth structure-reactivity study, using a tailored
methodology, for the rational design and development of bio-
responsive linkers.
Introduction
The specific release of bioactive compounds has become a
major issue in modern drug development. The eﬃcacy and
selectivity of the bond breaking process is a paramount com-
ponent for the success of prodrugs1 and targeted therapeutics
such as Antibody Drug Conjugates (ADC).2 For a delivery
system to be eﬀective, it must remain stable and active until
reaching its site of action. As a strategy for selective bond cleav-
age mechanisms, one can exploit singularities linked to path-
ologies or sub-cellular compartments including enzymatic
activity3 or a high glutathione level.4
In the field of pH-sensitive drug delivery systems, several
acid-sensitive linkers have been developed to respond to a pH-
shift. Typical examples are shown in Fig. 1. For delivery
systems, hydrazone,5 cis-aconityl6 and trityl bonds7 have been
the most widely investigated, but other linkers such as dialkyl
and diaryldialkoxysilane,8 orthoester,9 acetal,10 β-propionate,11
phosphoramidate,12 imine,13 vinyl ether,14 imidazole15 and
polyketal16 have also been described and reviewed.17
We have recently published a study on a homo-bifunctional
spiro di-orthoester (SpiDo) linker derivative which has shown a
fast lysosomal hydrolysis and a high stability in human
plasma.18 In the course of this work we have noticed that
despite many reports on acid-labile delivery systems, the
choice of a suitable starting point for the design of a biospeci-
fic release system remains mostly intuitive.
Most of the acid-sensitive linkers have been described for
diﬀerent applications and in diﬀerent model systems. Each
study mostly focused on the use of one type of acid-sensitive
linker, for one particular application, in one specific biological
system. The majority of the time, the pH-sensitive linkers are
first characterized in solution with their hydrolysis profiles at
pH 5.5 and 7.4, and then directly used in specific biological
applications. The scarce and disparate data do not provide a
precise and comprehensive overview on the chemical reactivity,
allowing the direct comparison of chemical structures and
guiding the rational design of acid-sensitive biospecific
linkers. For this reason, we report herein the pH sensitivity
profiles of the main acid-labile structures under standardized
conditions in solution, and further in cellular environments
using turn-on fluorescent probes.
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Results and discussion
Determination of hydrolysis profiles
Following a literature review, we designed analogs representa-
tive of known acid-sensitive chemical linkers. For the most
widely reported linkers, several derivatives have also been
synthesized to further expand the structure–acid lability–
relationship. Each of these derivatives includes a UV traceable
moiety to allow HPLC-UV detection. Hydrolytic profiles of all
compounds have been monitored in aqueous buﬀer solution
at pH 5.5 (to simulate lysosomal pH) and pH 7.4 (to simulate
serum conditions). A 10 mM solution of each molecule was
prepared in DMSO and diluted in buﬀer to obtain a 1 mM
solution. For pH 7.4 NaH2PO4/Na2HPO4 phosphate buﬀers
and for pH 5.5 KH2PO4/Na2HPO4 were prepared at 100 mM.
Each solution was immediately analyzed by analytical
HPLC (eluent A/B, A: NH3HCOOH solution (10 mM, pH 8.5)/B:
ACN; gradient: 5% B to 95% B in 20 minutes and
10 minutes of re-equilibration). The reaction was performed at
25 °C and the crude was injected every 30 minutes for up to
8 hours. The first measurement t1 was recorded after 30
seconds which is a result of the delay in sample preparation.
For each recorded time tx the amount of the non-hydrolyzed
product was measured by the calculation of the area under the
peak. Comparing with the calculated area at t1 the percentage
of the hydrolyzed product was calculated following the
formula:
% hydrolysis ¼ 100  ðAt1  AtxÞ
At1
for each pH the variation of % hydrolysis within the
time of the experiment was plotted. The half-life times t1/2
were estimated and the hydrolysis selectivity was measured
by the ratio:
t
1
2
 
pH 7:4
t
1
2
 
pH 5:5
when compounds were completely hydrolyzed at the first
measurement t1, a half-life time of less than 0.01 hours
(0.5 minutes) was attributed. In these particular cases we were
not able to determine if the compounds were hydrolyzed
within 10 seconds before the analysis (pH 5.5 or 7.4) or during
the analysis itself (pH 8.5). However considering the required
plasma stability (pH = 7.4) such functional groups were not
considered as potent leads to eﬃcient delivery systems.
Synthesis of the model compounds is straightforward (see
the ESI† for a full description of their syntheses) but requires
careful attention, requiring the use of mild acidic conditions
when handling pH-sensitive groups especially upon
purification.
Carbazate, oxime, imine, hydrazone and acylhydrazone
derived compounds
Compounds containing a carbon–nitrogen double bond (e.g.
hydrazone) are the most widely used structures for acid-labile
pro-drugs and the controlled delivery of doxorubicin, cisplatin
and other agents.5n–v In a similar manner, the imine (Schiﬀ
base) itself has already been used to achieve an acid-triggered
drug release.19 With compounds 1–8 in hand, we studied the
lability of the carbon–nitrogen double bond towards hydrolysis
at pH 5.5 and 7.4 (Fig. 2). This particular case gave binary
results. On the one hand, oxime 1, carbazate 4 and hydrazone
pyridine 7 were completely stable at both pH values; on the
Fig. 1 Examples of acid sensitive bonds.
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other hand imines 2, 3 and acylhydrazones 5 and 6 were com-
pletely hydrolyzed at the first measurement. It is known that
pyridine can be protonated in acidic media and thus can lead
to a specific acidic cleavage.20 However, under our conditions
we found that replacing a benzene ring (2) with a pyridine ring
(7) did not improve the stability.
Substituted heterocycles derived from benzaldehyde
The kinetics stability studies of heterocycles 9 to 11 were per-
formed to further examine the eﬀect of the heteroatoms on the
hydrolytic profiles of five membered rings in aqueous media
(Fig. 3 and S1†). At t1, imidazoline 9 and oxazolidine 10
showed complete hydrolysis at both pH values, while dioxo-
lane 11 displayed distinct hydrolysis profiles. At pH 5.5, 50%
of hydrolysis was detected after two hours while less than 5%
of hydrolysis was observed at pH 7.4. Extrapolation of the data
recorded at pH 7.4 gave a half-life of about 33 hours.
The influence of the ring size and steric eﬀects was studied
using dioxolane compounds 11 to 13 (Fig. 4 and S2†). Com-
pound 12 bearing one extra methyl compared to compound 11
showed a better stability at pH 5.5 with a half-life of 4.2 hours.
However, it led to a 2-fold decrease in the half-life at pH 7.4.
1,3-Dioxane type compound 13 revealed to be the most stable
of this series at both pH values, with no trace of p-anisalde-
hyde being observed after 6 hours. This result is consistent
with the previous work by Harper21 and others.22
Following the work by Bundgaard and co-workers who
reported the hydrolysis kinetics of several oxazolidines, and
assessed their suitability as prodrug forms for beta-amino
alcohols and/or carbonyl-containing compounds,23 oxazoli-
dines 15–21 were synthesized and their pH sensitivity
recorded. Derivatives 15 and 16 showed complete hydrolysis at
t1 at both pH values (Fig. 5, S3 and S4†). Oxazolidine 17 was
very reactive toward hydrolysis with a half-life time of less than
20 min at pH 5.5. The addition of a second electron donating
group did not increase the rate of hydrolysis, and the half-lives
of 18 were very similar at both pH values. As expected, the sub-
stitution of benzaldehyde with an electron withdrawing group
in 19 decreased the rate of hydrolysis at both pH values. A
similar eﬀect was also observed with the pyridine derivative
20. It is known in the literature that the stability of the oxazoli-
dine can be tuned by the steric hindrance on the hetero-
cycles.23 However in this case, derivative 21 revealed to be very
unstable at both pH values.
We next turned our attention to the hydrolysis of the ketal
moieties (Fig. 6, S5 and S6†). They are well known acid-sensi-
tive moieties that were originally found to be useful as protect-
ing groups for aldehydes.24 Derivative 22 had a half-life of
0.8 hours and 12.2 hours at pH 5.5 and 7.4 respectively. The
rate of hydrolysis was increased by adding an electron donat-
ing methoxy group 23. Moreover, both compounds showed a
good stability at pH 7.4. Derivative 24 presented the highest
ratio of hydrolysis between both pH values. The N-ethoxyben-
zylimidazole derivative 25 showed a slower hydrolysis kinetics
at pH 5.5 and a better stability at pH 7.4 compared to its
Fig. 2 Hydrolysis kinetics of compounds 1–7 at pH 5.5 and 7.4 (S =
compound stable during the time of the experiment (0% hydrolysis)).
Fig. 3 Inﬂuence of heteroatoms on the hydrolysis of ﬁve membered
ring systems. Hydrolysis kinetics of compounds 9–11 at pH 5.5 and 7.4.
Fig. 4 Inﬂuence of steric eﬀects and size of the ring on dioxane and
dioxolane type ring systems. Hydrolysis kinetics of compounds 11–13 at
pH 5.5 and 7.4 (S = compound stable during the time of the experiment
(0% hydrolysis)).
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parent diacetal compound 24. These last results are in agree-
ment with a previous study by Yang and coworkers.15a
Siloxane, acetal, β-thiopropionate THP and carbamate derived
compounds
Widely used in organic chemistry as protecting groups,24 silyl
ethers have also been used as hydrolysable monomers in bio-
degradable polymers,8 and it is known that the increase in the
size of the substituents on the silicon atom significantly
reduces the linker hydrolysis rate under acidic conditions.
Derivative 26 hydrolyzed 4 times slower at physiological pH as
compared to pH 5.5 (Fig. 7 and S7†). Two additional siloxane
acetals derived from 26 (where the two phenyl rings in 26 were
substituted by two methyl or two n-butyl groups) were syn-
thesized but could not be purified due to their high instability.
Based on a similar scaﬀold, acetonide 27 was found to be very
unstable and was completely hydrolyzed at t1. In 2004, Hubbell
and co-workers were able to show that 3-sulfanylpropionyl or
4-sulfanylbutyryl esters could be used for oligodesoxynucleo-
tide vectorisation.25 In our study, the β-thiopropionate deriva-
tive 28 showed moderate stability at both pH values but
suﬀered from poor selectivity with a ratio of 1.5. Finally, THP-
based and carbamate compounds 29 and 30 were completely
stable at both pH values as expected.
Our results reveal that although these molecular structures
were described to possess good stability at pH 7.4 and
increased lability at pH 5.5, important discrepancies in their
relative profiles could be observed. The hydrolysis rate can
change dramatically, not only from one family to the other,
but also within a specific family depending on the substituent
pattern of the tested derivatives. However based on that study
it seems possible to categorize the diﬀerent structural mole-
cular motifs according to their average hydrolysis pattern.
All tested structures have thus been ranked according to the
following criteria (Fig. 8):
-Non-hydrolysable when no hydrolysis was observed under
our conditions at pH 5.5
-Fast hydrolysis when the half-life time at pH 5.5 was below
1 hour.
-Highly selective hydrolysis when the ratio
t1=2 ðpH 7:4Þ
t1=2 ðpH 5:5Þ
was
more than 15.
-Selective hydrolysis when the ratio
t1=2 ðpH 7:4Þ
t1=2 ðpH 5:5Þ
was between 2
and 15.
-Non-selective hydrolysis when the ratio
t1=2 ðpH 7:4Þ
t1=2 ðpH 5:5Þ
was
below 2.
We then decided to go further in this study and validate if
the in-solution reactivity could be translated to usable data for
the design of endosomal release systems. For this purpose, we
decided to incorporate selected acid-labile structures into turn-
Fig. 6 Eﬀects of the substitution on the hydrolysis rate of ketal deriva-
tives. Hydrolysis kinetics of compounds 22–25 at pH 5.5 and 7.4.
Fig. 7 Hydrolysis rates of siloxane, acetal, β-thiopropionate, tetrahydro-
pyranyl ether and carbamate derivatives. Hydrolysis kinetics of com-
pounds 26–30 at pH 5.5 and 7.4 (S = compound stable during the time
of the experiment (0% hydrolysis)), R = (CH2)2-O-(CH2)2-NHCO-C5H6.
Fig. 5 Eﬀects of the substitution of the benzaldehyde moiety on the
hydrolysis rate of oxazolidine derivatives. Hydrolysis kinetics of com-
pounds 15–21 at pH 5.5 and 7.4.
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on FRET-based probes that will enable us to measure the in-
cell endosomal release under standardized and comparable
conditions. More specifically, we chose four derivatives belong-
ing to four diﬀerent categories:
-An acylhydrazone derivative which hydrolyzes rapidly but
not selectively according to the pH.
-A dialkyl acetal derived from o-anisaldehyde with kinetic
profiles similar to the spiro di-orthoester already studied but
showing an improved selectivity for a low pH.
-A tetrahydropyranyl ether derivative which showed no
hydrolysis under our conditions.
Design and synthesis of FRET-type probes
On the basis of the previously reported TAMRA-orthoester-
(BHQ)-2 probe,18 we designed four FRET-based probes includ-
ing the acid-sensitive linker between a fluorophore TAMRA,
and a quencher (BHQ)-2 (TAMRA-acid sensitive linker-(BHQ)-
2). It is worth noting that particular attention has to be paid
when purifying the acid sensitive intermediates and final
probes. Syntheses of TAMRA-acylhydrazone-(BHQ)-2, TAMRA-
orthoester-(BHQ)-2 and TAMRA-amide-(BHQ)-2 have been pre-
viously reported (Fig. 9).18
Synthesis of TAMRA-THP-(BHQ-2) probe P1
The synthesis started from (3,4-dihydro-2H-pyran-2-yl)metha-
nol 31 which was converted to carboxylic acid 33 in two steps
(Scheme 1). The coupling of 33 with propargylamine gave the
corresponding amide 34 in good yield. The reaction of 34 with
alcohol 35 in the presence of a catalytic amount of p-TsOH
gave the THP derivative 36. A microwave assisted click reaction
between alkyne 36 and an azide derivative of BHQ-2 gave 37
which was further functionalized by Michael addition with
Fig. 8 Classiﬁcation of pH-sensitive structures depending on the rate of hydrolysis at pH 5.5 and the selectivity of hydrolysis measured by the ratio
of hydrolysis at pH 7.4 vs. pH 5.5.
Fig. 9 Previously reported acid sensitive FRET based probes.18
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4798 | Org. Biomol. Chem., 2016, 14, 4794–4803 This journal is © The Royal Society of Chemistry 2016
Pu
bl
ish
ed
 o
n 
06
 M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ité
 d
e S
tra
sb
ou
rg
, S
er
vi
ce
 C
om
m
un
 d
e l
a D
oc
um
en
ta
tio
n 
on
 2
/1
2/
20
20
 8
:1
9:
49
 A
M
. 
View Article Online
TAMRA-SH to give probe TAMRA-THP-(BHQ-2) P1 after careful
purification by preparative HPLC (NH3HCO2H/ACN, pH 8.5).
Synthesis of TAMRA-acetal-(BHQ-2) probe P2
Following the procedure described by Zhang and Zhao,26 o-an-
isaldehyde 38 was reacted with chloroethanolamine at 90 °C to
give the corresponding acetal 39 which was further functiona-
lized to the corresponding bis-azide 40 after treatment with
sodium azide. Finally, a double copper catalyzed cycloaddition
of bis-azide 40 with (BHQ-2)-alkyne and TAMRA-alkyne deriva-
tives26 gave the TAMRA-acetal-(BHQ-2) probe P2 in 10%
yield.27 The yield of the last reaction was unfavorably low
because of solubility issues which favored the formation of the
TAMRA-acetal-TAMRA side product in 72% yield.
Eﬀect of pH on hydrolysis of FRET-based probes
Before engaging in-cell studies, we validated that the FRET
probes had similar in-solution hydrolytic profiles to their
parent molecules. Kinetic fluorescence measurements were
conducted at pH 3 to 7 to evaluate the stability of the diﬀerent
probes for 15 hours in aqueous buﬀer solution (Fig. 10). For
the THP-based probe, no significant hydrolysis was observed
within the range of tested pH values. The acetal-based probe
P2 was respectively hydrolyzed at 34% and 16% at pH 3 and 4
after 15 hours and showed little hydrolysis at pH 5 and 6. In
agreement with the results of the small analogs, the hydrolysis
of the acylhydrazone derivative did not display a strong pH-
selectivity; only two diﬀerent profiles were observed from pH
3–7. Alternatively, the hydrolysis of the spiro diorthoester
based probe P5 showed a strong pH-dependency. It was totally
and instantly hydrolyzed below pH 3, whereas 1 and 4.5 hours
were necessary to get complete hydrolysis at pH 4 and 5,
respectively. At pH 6 and 7, 65% and 24% of hydrolysis,
respectively, were observed after 15 hours. As expected the
general profile of the hydrolysis rate is in agreement with data
obtained by HPLC for the corresponding analogs of THP (non-
hydrolysable), acylhydrazone (hydrolysable, non-selective),
orthoester and acetal (hydrolysable, selective).
However, the lability of the pH-sensitive linkers under
acidic conditions appears to be much less important after
incorporation into the FRET-based probe. Interestingly, these
four probes showed slightly diﬀerent profiles (from completely
stable to quickly hydrolysable and from selective to non-selec-
tive). The next goal was to reveal which one will be the most
suitable to achieve specific endosomal release.
Confocal microscopy and flow cytometry analysis
The biosensitivities of the diﬀerent probes (P1–P5) were
further studied in tissue cultures and cells were analyzed by
both confocal microscopy to confirm lysosomal cleavage, and
flow cytometry to provide quantitative information about intra-
cellular probe hydrolysis. First BNL-CL2, a mouse liver cell
line, was loaded with the diﬀerent probes (1 µM, 90 min) and
the nuclei were stained with Hoechst 33258. The cells were
imaged by confocal microscopy and representative images are
shown in Fig. 11. The TAMRA-amide-(BHQ-2) probe P3 was
used as a non-hydrolysable control. Preliminary control experi-
ments were performed using a small TAMRA derivative, such
Scheme 1 Synthesis of TAMRA-THP-(BHQ)-2 and TAMRA-acetal-(BHQ-2) probes P1 and P2. Reagents and conditions: (a) 32, NaH, THF, 0 °C, 3 h,
77%; (b) LiOH, MeOH, H2O, rt, 5 h, quant.; (c) propargylamine, HBTU, DIEA, DMF, rt, 16 h, 71%; (d) 35, p-TsOH, CH2Cl2, 0 °C to rt, 2 h, 77%; (e) sodium
ascorbate, CuSO4,
tBuOH, H2O, THF, 4 Å molecular sieves, microwave, 50 °C, 1 h, 74%; (f ) CH2Cl2, MeOH, Et3N, rt, 2 h, 62%; (g) chloroethanolamine,
p-TsOH, benzene, Dean–Stark, 90 °C, 16 h, 40%; (h) NaN3, DMF, 80 °C, 16 h, 26%; (i) CuSO4, sodium ascorbate,
tBuOH, THF, H2O, rt, 3 h, 10%.
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Fig. 10 Hydrolysis kinetics of FRET-based probes P1, P2, P4 and P5 at pH 3 (red lines), 4 (green lines), 5 (light blue lines), 6 (dark blue lines) and 7
(purple lines). All data were recorded in triplicate at room temperature on a microplate reader and with a probe concentration of 0.5 µM in buﬀers
(100 mM citric acid/phosphate buﬀer; pH 3–7).
Fig. 11 In vitro imaging of BNL CL.2 cells loaded with probes P1–P5; red channel: activable probe (1 µM, 90 min), blue channel: Hoechst nuclei
staining (5 µg mL−1, 30 min); scale bar: 25 µM.
Communication Organic & Biomolecular Chemistry
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as the released reporter generated after hydrolysis of the acid-
sensitive probes. This derivative was incubated in the presence
of BNL CL.2 hepatocytes at 1 µM for 2 hours and imaging of
the cells revealed an absence of fluorescence compared with
the acid-sensitive probe P5 (Fig. S8†). Therefore, the intracellu-
lar fluorescence signal can be directly correlated to the intra-
cellular hydrolysis of the probes, even if extracellular
hydrolysis of the probe happens.
TAMRA-orthoester-(BHQ-2) and TAMRA-acylhydrazone-
(BHQ-2) probes P5 and P4, respectively, displayed strong stain-
ing distributed predominantly in the peri-nuclear region of
cytoplasm that is consistent with lysosomal cleavage
(Fig. 11).18 To obtain a quantitative evaluation of the probe
hydrolysis, NIH/3T3 cells were incubated with probes P1–P5
for 4 hours, suspended in media and analyzed by flow cytome-
try (Fig. 12). This experiment showed that the TAMRA-ortho-
ester-(BHQ-2) probe P5 was the most eﬃcient probe followed
by the TAMRA-acylhydrazone-(BHQ-2) probe P4. The TAMRA-
acetal-(BHQ-2) probe P2 showed only very little hydrolysis com-
pared to the non-hydrolysable control probe. These results are
in good agreement with the hydrolysis rates measured for
probes P1–P5 in solution (Fig. 10). Indeed acylhydrazone and
orthoester-based probes showed significant hydrolysis at pH 5
and 6 after 1.5 hours while the acetal-based probe showed
little to no hydrolysis at pH 5 and 6 after the same period of
time. The TAMRA-acetal-(BHQ-2) probe P2 did not shown any
lability with little to no fluorescence observed (Fig. 11). Inter-
estingly, the TAMRA-THP-(BHQ-2) probe P1 shows a fluo-
rescence signal similar to the TAMRA-acylhydrazone-(BHQ-2)
probe P4.
Conclusion
In this study, the hydrolytic cleavage of a wide variety of mole-
cular structures that were reported for their use in pH-sensitive
delivery systems was carefully examined. Standardized data
measured by HPLC enabled the establishment of a first classi-
fication of these groups based on their hydrolysis profiles at
pH 5.5 and their relative hydrolysis at pH 5.5 vs. pH 7.4. From
this classification four chemical functions belonging to three
diﬀerent categories were selected and used as core motifs to
design FRET-based probes. These probes were used to quantify
and compare the lysosomal cleavage of the diﬀerent acid-sensi-
tive structures (orthoester, acylhydrazone, acetal and tetra-
hydropyranyl ether).
Surprisingly, a wide variety of hydrolytic stability profiles
could be found among the chemical functionalities suppo-
sedly suitable for pH release systems. Even within a structural
family, a slight modification of the substitution pattern could
have an unsuspected outcome on the hydrolysis stability. Fur-
thermore, we also showed that incorporating these small
motifs into larger molecular constructs slowed down their
hydrolysis without modifying their relative reactivity. These
observations underline the need to carefully design a reporting
probe to validate the actual stability of the cleavable group in
the environment of the delivery system. Our tests also showed
that only the most reactive functional groups underwent sig-
nificant lysosomal cleavage according to flow cytometry
measurements. Interestingly, these are the motifs that proved
to be very diﬃcult to synthesize and to store. They showed
almost complete hydrolysis in our HPLC assay after 30
seconds. These last results question the validity of the claimed
acid-based mechanism of action of some described drug
release systems. We believe that a structure-reactivity study and
a methodology assessing in-cell hydrolysis of the main func-
tional groups will provide a stimulating insight for the rational
design and development of improved acid-sensitive linkers.
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